article thumbnail

EFPIA states AI rules must “enable not hinder” pharma R&D

Drug Discovery World

Significantly for drug discovery, ‘scientific research and development’ is excluded from the scope of the Act, though this will be defined further in future guidance. Diana Spencer, Senior Digital Content Editor, DDW The post EFPIA states AI rules must “enable not hinder” pharma R&D appeared first on Drug Discovery World (DDW).

article thumbnail

Claims that AI will “revolutionise pharma R&D” are (almost entirely) hype

DrugBaron

Both the cost and the time required for each new drug approval have increased exponentially for decades (aptly tagged ‘Eroom’s Law’, being the inverse of price drops and speed gains in the semiconductor industry). There is, of course, no evidence of whether the claims made for AI in discovery and development are hype or reality.